Meth Use Treatment Study

Researchers at the University of Washington are partnering with individuals who want to quit or reduce their methamphetamine use to evaluate how a medication can help. Join our compensated study today!

Fast Facts

meth & opioid use in the last 30 days

interested in quitting meth

18-65 years old

Compensation Provided

Conducted in Seattle, WA

Study Background

Can an injectable medication help people reduce meth use?

Right now, there are no treatments specifically approved for methamphetamine use disorder. This study will examine an injectable medication to see if it helps people reduce their meth use. If you have used meth and any form of opioid in the past month, and you’re interested in quitting, you may be eligible to participate.

Study visits are in-person twice weekly at Harborview Medical Center. The screening phase may last 10-21 days and the medication phase is an additional four months.

Your participation in this study may help researchers improve treatment approaches for methamphetamine use disorder. Advance research today and join our compensated study!

Additional Information

The purpose of this research study is to test an injectable medication as a possible treatment for methamphetamine use disorder in people who also use opioids.

You may qualify for this study if you meet the following criteria.

Key Criteria:

  • 18-65 years old
  • Able to understand and speak English
  • Have used methamphetamines and any form of opioid within the past 30 days
  • Interested in reducing or stopping meth use
  • Not pregnant, breastfeeding, or planning to become pregnant

If you are a good match for the study, you will receive 3 injections of either active or placebo study medication. A placebo looks like the medication we are testing but does not include any active medicine and it helps us understand if the active medication is working.

You will receive an active sublingual medication, meaning given under the tongue, for 2-3 days before receiving the injectable study medication. On the next day following your last sublingual medication, you will get your first injection. Second and third injections will be given at Weeks 5 and 9. Follow-up appointments will be completed through Week 16.

During the 3-month medication period, you will need to come to the clinic two times a week for assessments and to receive your study medication. This study also requires weekly cognitive behavioral therapy sessions focused on your recovery, which will be conducted during a study visit.

Study information will be kept confidential.

You will receive compensation up to $735 for your time and efforts.

No, there is no cost for you to participate in the study. Study medication and assessments will be provided to you for free.